Ann Merchant
Director/Board Member at ALVOTECH
Net worth: 144 444 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Stamp | M | 62 | 5 years | |
| Robert Bradway | M | 61 | 18 years | |
| Richard Davies | M | 62 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 18 years |
| Vilhelm Wessman | M | 54 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 12 years |
| Helga Zharov | F | 57 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 years |
| Linda McGoldrick | M | 69 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 years |
| Marc Cluzel | M | 69 | 12 years | |
| Faysal Kalmoua | M | 48 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 years |
| David Reese | M | 61 | 19 years | |
| Esteban Santos | M | 56 | 17 years | |
| Krisja Vermeylen | F | 62 | 7 years | |
| Joel Morales | M | 46 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 years |
| Anil Okay | M | 38 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 6 years |
| Julia Neugebauer | M | - | 18 years | |
| Árni Harðarson | M | 57 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 years |
| Daniel Palmacci | M | - | 4 years | |
| Joseph E. McClellan | M | 50 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 5 years |
| Ming Li | M | 47 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 years |
| Sigridur Elin Gudlaugsdottir | F | - |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | - |
| Luisa Ciccarelli | F | - | 3 years | |
| Lisa Graver | F | 53 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 years |
| Matthew Busch | M | 50 | 20 years | |
| Tomas Ekman | M | 56 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 5 years |
| Robert Eckert | M | 69 | 21 years | |
| Ronald Sugar | M | 75 | 14 years | |
| Benedikt Stefansson | M | - | 2 years | |
| Sijmen de Vries | M | 65 | 10 years | |
| Simon Turton | M | 56 | 10 years | |
| Günter Wellnhofer | M | - | 30 years | |
| Ralf Ostendorp | M | - | 25 years | |
| Eamonn Nolan | M | - | 3 years | |
| Giedrius Zunda | M | - | 1 years | |
| Stephen Parker | M | 65 | 2 years | |
| Dan Palmer | M | - | - | |
| Steve Ellul | M | - | 2 years | |
| Michael Brosnan | M | 69 | 6 years | |
| Derek Miller | M | - | 21 years | |
| Sean Gaskell | M | 42 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 years |
| Robert Mayer | M | - | 3 years | |
| Tim Demuth | M | 50 | 2 years | |
| Isabelle Degbegni | F | - | - | |
| Fiona Sharp | F | - | - | |
| Lucinda Crabtree | M | 45 | 1 years | |
| Dmitry Zamoryakhin | M | 44 | 3 years | |
| Thomas Biegi | M | - | 4 years | |
| Sharon Curran | F | 56 | 5 years | |
| George Golumbeski | M | 67 | 6 years | |
| Andrew Cheng | M | 57 | 2 years | |
| Charlotte Lohmann | F | 54 | 12 years | |
| Barbara Krebs-Pohl | M | - | 26 years | |
| Klaus de Wall | M | - | 19 years | |
| Jean-Paul Kress | M | 59 | 5 years |
Connections Chart
Multi-company connection
Former connections
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 48 | 48.48% |
| Germany | 29 | 29.29% |
| Luxembourg | 15 | 15.15% |
| Iceland | 14 | 14.14% |
| United Kingdom | 8 | 8.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ann Merchant
- Personal Network
